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ABSTRACT
PURPOSE Technology could transform routine decision making by anticipating
patients’ information needs, assessing where patients are with decisions and
preferences, personalizing educational experiences, facilitating patient-clinician
information exchange, and supporting follow-up. This study evaluated whether
patients and clinicians will use such a decision module and its impact on care,
using 3 cancer screening decisions as test cases.
METHODS Twelve practices with 55,453 patients using a patient portal partici-

pated in this prospective observational cohort study. Participation was open to
patients who might face a cancer screening decision: women aged 40 to 49 who
had not had a mammogram in 2 years, men aged 55 to 69 who had not had a
prostate-specific antigen test in 2 years, and adults aged 50 to 74 overdue for
colorectal cancer screening. Data sources included module responses, electronic
health record data, and a postencounter survey.
RESULTS In 1 year, one-fifth of the portal users (11,458 patients) faced a poten-

tial cancer screening decision. Among these patients, 20.6% started and 7.9%
completed the decision module. Fully 47.2% of module completers shared
responses with their clinician. After their next office visit, 57.8% of those surveyed thought their clinician had seen their responses, and many reported the
module made their appointment more productive (40.7%), helped engage them
in the decision (47.7%), broadened their knowledge (48.1%), and improved communication (37.5%).
CONCLUSIONS Many patients face decisions that can be anticipated and proac-

tively facilitated through technology. Although use of technology has the potential to make visits more efficient and effective, cultural, workflow, and technical
changes are needed before it could be widely disseminated.
Ann Fam Med 2017;15:217-224. https://doi.org/10.1370/afm.2063.
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INTRODUCTION

T

oday’s patients face complex medical decisions. Clinicians traditionally support patients with decisions by giving advice during inperson visits. Unfortunately, the competing demands and time constraints associated with office visits limit the help clinicians can realistically
provide.1,2 More importantly, both difficult and even routine choices might
entail a “decision journey”—that is, the support required may extend over
time, a period during which patients may contemplate options, gather
additional information, confer with family and friends, consider personal
preferences, and address worries or concerns.3-5 These tasks are beyond
what can be accomplished during an office visit.6-9
Although the components of a “good” medical decision journey have
been well described,10-13 patients generally receive limited support during these journeys.14-17 Patients want to be included in decisions, yet
many decisions occur with minimal patient input.17-19 When conversations
do take place, they rarely include all elements needed for an informed
decision.14,18,20 One proven solution is to use decision aids. Decision
aids increase knowledge, reduce decisional conflict, engage patients,
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and reduce rates of elective invasive procedures and
unnecessary testing.21-23 Yet it is difficult for clinicians
to routinely use decision aids, and accordingly, they
are not commonly used.24-29
Health information technology (HIT) offers a
potential to systematically automate decision-making
processes outside the constraints of clinical encounters. This strategy could enable visits with clinicians
to focus on decision elements that occur best in person.30,31 HIT has the capacity to anticipate decision
needs through programmed logic, deliver information
and decision support before visits, collect patientreported information, share information with the clinician about where the patient is with decisions and
preferences, set a decision-making agenda, and even
follow up on next steps (Figure 1).

METHODS
This pragmatic observational cohort study evaluated
how clinicians and patients used an integrated decision
module and explored the module’s impact on care for 3
routine decision scenarios: when to start breast cancer
screening, how to be screened for colorectal cancer,
and not being screened for prostate cancer. These 3
screening topics were selected because they represent
common patient decisions—even prostate cancer
screening, which although not recommended for the
general population, is often inquired about by patients
and may be appropriate for a subset of men willing
to risk screening harms.32 The study was reviewed by
the Virginia Commonwealth University Institutional
Review Board (HM14750).

Setting
Twelve primary care practices in northern Virginia
participated. The practices shared 1 of 2 electronic
health records (EHRs), Allscripts Enterprise or Professional. All practices used a central patient portal,
called MyPreventiveCare.33 At the time of the study,
55,453 unique patients (34.5% of the practice population) had a portal account and 23,546 used the portal
during the study period. Although portal users were
representative of the practices, prior investigation
demonstrated users were more likely to be older or
have comorbidities, and were slightly less likely to be
African American or Hispanic.34
Participants
Patients age 50 to 75 years who were overdue for
colorectal cancer screening,35 women aged 40 to 49
years who had not had a mammogram in 2 years,
and men aged 55 to 69 years who had not obtained
a prostate-specific antigen (PSA) test in 2 years were
invited to complete the decision module. Patients
were excluded if they had a prior diagnosis of
colorectal, breast, or prostate cancer, or prior abnormal screening test results.
Invitations to use the module occurred in 3 phases.
In phase 1 (January 6, 2014, through February 16,
2014), eligible patients who logged into the portal were
prompted to review the module. In phase 2 (February
17, 2014, through May 15, 2014), eligible patients who
had a visit scheduled 2 weeks in advance were e-mailed
an invitation to review the module, 2 weeks, 1 week,
and 2 days before their visit. In phase 3 (May 26, 2014,
through August 15, 2014), any eligible patient was

Figure 1. Conceptual model for engaging patients through an informed decision-making module
embedded in a patient portal and electronic health record.
1. Patient with decision
needs identified

Module assessment
and education

4. Information sharing
with clinician

2. Preference
questions

3. Personalized educational material

5. Primed
discussion

6. Clinical
decision

7. Postencounter patient and
clinician input and follow-up
Note: To engage patients in their decision, the informed decision-making (IDM) module guides patients and clinicians through a series of 7 steps that can be applied to
a wide range of decisions beyond the test case (cancer screening) investigated in this study. The IDM module (1) reaches patients outside the confines of an office visit
to explore a potential decision by completing the module; (2) walks patients through an intake that assesses personal preferences, knowledge, and needs, and patients’
readiness to make a decision; (3) provides personalized educational material tailored to patients’ stated preferences and decision stage; (4) allows patients to share their
preferences and decision needs with their clinician; (5) prompts patients and clinicians to use the reported information to make a decision; (6) guides the patient to
make a choice, which can include deferring the decision; and (7) invites patients and clinicians to provide input after the encounter.
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e-mailed up to 3 weekly invitations to review the module, irrespective of appointment status.

assistance, preferred format for receiving information
and statistics, and planned next steps.
Based on patients’ responses, the module assembled
Decision Module
a customized educational page that included informaThe decision module promoted the 2012 prostate,
tion about topics of greatest interest to patients (eg,
2009 breast, and 2008 colon cancer screening recrisk of cancer, benefits or harms of screening, screening
ommendations made by the US Preventive Services
logistics) in the format they preferred (ie, words, numTask Force.32,35,36 It included 7 components (Figure 1).
bers, pictures, or stories). Questions were derived from
The system identified eligible patients through wellvalidated instruments when possible.37-39
established programmed logic by querying the EHR
The module asked patients if they would like to
and portal data.33 It flagged eligible patients when they discuss screening at their next office visit and if they
used the portal (phase 1) or during a daily scheduled
would like a summary to be automatically forwarded
query (phases 2 and 3) and then invited patients by
to their clinician for review. The summary included
prompt or e-mail to complete a previsit assessment in
whether patients had made a screening decision, the
the decision module. Seventeen interactive questions
topics they wanted to discuss, their fears and worexplored patients’ stage of readiness for deciding about ries, and their preferred level of decision control.37
cancer screening, information needs and fears, desired
Supplemental Appendix 1, available at http://www.
annfammed.org/content/15/3/217/
suppl/DC1/, displays screenshots
Table 1. Patients Starting and Completing the Informed Decisionof MyQuestions, educational
Making Module by Study Phase and Cancer Screening Decision
content, and clinician summaries.
The system automatically sent
Cancer Screening Decision
a postencounter questionnaire
Module Use
Colon
Breast
Prostate
Total
to both the patient and cliniOverall use: phases
cian after the office visit. The
1, 2, and 3 combineda
questionnaire sought feedback
Eligible, No.
6,329
3,733
1,396
11,458
Starters, No. (%)
1,249 (19.7)
638 (17.1)
468 (33.5)
2,355 (20.6)
on the module and the events
903
224
190
489
Completers, No.
before, during, and after the clini38.3
47.9
9.8
39.2
Of starters, %
cal encounter. Nonresponders
7.9
6.0
5.1
7.7
Of eligible, %
received up to 5 reminders.
Phase 1: prompt on
The design of the module was
MyPreventiveCare log-ina
informed by a 2-year process of
Eligible, No.
542
297
171
1,010
patient and stakeholder engageStarters, No. (%)
154 (28.4)
70 (23.6)
86 (50.3)
310 (30.7)
72
21
12
39
Completers, No.
ment including focus groups
23.2
24.4
17.1
25.3
Of starters, %
to identify important module
7.1
12.3
4.0
7.2
Of eligible, %
content; patient iterative input of
Phase 2: prompt via e-mail
draft module content; cognitive
before appointmenta
and usability testing consistent
Eligible, No.
354
171
85
610
with national standards40; and
Starters, No. (%)
140 (39.5)
53 (31)
53 (62.4)
246 (40.3)
129
35
19
75
Completers, No.
a patient, clinician, and health
52.4
66.0
35.9
53.6
Of starters, %
system workgroup that met quar21.1
41.2
11.1
21.2
Of eligible, %
terly for 2 years to help plan the
Phase 3: prompt via e-mail
decision module design, implea
without an appointment
mentation, and interpretation of
Eligible, No.
5,136
3,220
1,080
9,436
findings.41 A clinician from each
Starters, No. (%)
469 (9.1)
264 (8.2)
189 (17.5)
922 (9.8)
practice served on the clinician
338
87
77
174
Completers, No.
36.7
46.0
29.2
37.1
Of starters, %
workgroup and helped to stan3.6
8.1
2.4
3.4
Of eligible, %
dardize and promote implementation at his or her office.
Phases 1, 2, and 3 combined: January 2, 2014, through August 15, 2014. Phase 1: January 2, 2014, through
a

February 16, 2014. Phase 2: February 17, 2014, through May 25, 2014. Phase 3: May 26, 2014, through
August 15, 2014.

Outcomes
Primary outcomes included
measures of how the decision
module was used and its impact

Note: The difference in starting and completing the decision module was statistically different for breast vs
colorectal (P =.001), breast vs prostate (P <.001), and colorectal vs prostate cancer (P <.001) screening decisions. The difference in starting and completing the decision module was statistically different for phase 1 vs
phase 2 (P <.001), phase 1 vs phase 3 (P <.001), and phase 2 vs phase 3 (P <.001).
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on decision making. We used 5 data sources: (1) the
EHR (demographics, diagnoses, screening status, module eligibility), (2) the portal (health risk assessment
responses, prompt, or e-mail invitation receipt), (3) the
decision module (patients’ responses, paradata–clicks
within the decision module pertaining to use of educational materials),42,43 and (4) the patient postencounter questionnaire and (5) the clinician postencounter
questionnaire (see Supplemental Appendices 2 and 3,
respectively, for the questionnaires, available at http://
www.annfammed.org/content/15/3/217/suppl/DC1/).
Decision module uptake—measured by the number of eligible patients who started and completed the
module—was calculated by race, ethnicity, sex, preferred language, insurance type, and phase of module
invitation. Measures of module use included educational content patients reviewed (paradata), whether
patients elected to share responses with their clinician,
and whether patients believed their clinician reviewed
their forwarded summary. EHR data indicated whether
patients obtained breast, colorectal, or prostate screening within 3 months of using the module.
Analysis
The analysis included all patients with a
MyPreventiveCare account who met eligibility criteria. Patients were subdivided
into starters and nonstarters, and starters
were further subdivided into completers or
noncompleters. We used χ2 tests for independent group comparisons, generalized
linear mixed models (GLMMs) for dependent group comparisons, and ANOVA
to compare time to follow-up between
groups. We used a GLMM when comparing phase eligibility to include a patientlevel random effect that accounted for
patients being eligible in multiple phases.
We did not adjust for other covariates. All
analyses were completed using SAS version 9.4 (SAS Institute).

most likely, while patients faced with breast cancer
screening were least likely, to start and complete the
module (P <.001).
Patients eligible in phase 2 were most likely to
start the module (phase 1, 2, and 3 = 20.6%, 30.7%,
and 9.8%, P <.001) and complete the module (phase 1,
2, and 3 = 7.9%, 21.1%, and 3.6%, P <.001) (Table 1).
Although phase 3 had the lowest percentage of starters
and completers, because many patients were included
in phase 3, it yielded the largest absolute number of
starters and completers. A detailed analysis of module
attrition has been previously reported.44
When the module was used, paradata indicated that
291 patients (23.6%) clicked on at least 1 educational
resource in the module (Supplemental Appendix 1,
section 16)—an average of 3.5 resources per patient.
The most frequent information patients reviewed
were options for getting screened (206 patients,
70.8%), what screening test works best (145 patients,
49.8%), problems or complications from screening
(133 patients, 45.7%), and how the test is performed
(120 patients, 41.2%). Among the 1,044 patients who

Table 2. Use of the Informed Decision-Making Module by
Demographic Characteristics
Module Starters
Characteristic

Noncompleters

Age, mean (SD), y

53.5 (8.3)

Total, No. (%)

1,452 (12.7)

54.9 (8.2)
903 (7.9)

Module
Nonstarters
52.4 (8.2)
9,103 (79.4)

Sex
Male
Female
Race, No. (%)
Asian
African American

472 (11.1)

3,201 (75.0)

857 (11.9)

431 (6.0)

5,902 (82.1)

132 (11.4)

60 (5.2)

966 (83.4)

62 (12.6)

63 (12.8)

67 (11.7)

Other

172 (9.5)

Unreported
Ethnicity, No. (%)
Non-Hispanic
Unknown
Language, No. (%)
English
Other
Insurance type, No. (%)
Commercial

618 (8.3)

368 (74.6)
5,788 (78.0)

43 (7.5)

464 (80.8)

119 (6.6)

1,517 (83.9)

38 (8.5)

364 (81.8)

1,065 (13.5)

658 (8.4)

6,153 (78.1)

344 (11.0)

207 (6.6)

2,586 (82.4)

1,249 (13.3)

770 (8.2)

7,375 (78.5)

203 (9.8)

133 (6.5)

1,728 (83.7)

1,304 (13.8)

782 (8.3)

7,349 (77.9)

43 (9.7)

Hispanic

Decision Module Use
During the nearly 1-year study period,
11,458 patients (20.7% of 55,453 unique
portal users) faced a screening decision for
colorectal cancer (6,329 patients), breast
cancer (3,733 patients), or prostate cancer
(1,396 patients) (Table 1). Prompted by the
invitation, 2,355 patients started and 903
completed the module. Patients faced with
a prostate cancer screening decision were

595 (13.9)

1,019 (13.7)

White

RESULTS

ANNALS O F FAMILY MEDICINE

Completers

Medicare

92 (17.2)

Medicaid

1 (20.0)

69 (12.9)
0 (0)

374 (69.9)
4 (80.0)
1,376 (92.8)

55 (3.7)

52 (3.5)

Yes

538 (14.3)

347 (9.3)

2,861 (76.4)

No

914 (11.9)

556 (7.2)

6,242 (80.9)

None
Prior screening, No. (%)

Note: Given the large sample size, all differences across groups (noncompleters, completers, and
nonstarters) were statistically significant (P <.001) with the exception of Medicaid insurance type.
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reached the forwarding question, 493 (47.2%) indicated
a desire to forward a summary to their clinician.

A sizable subset of patients and clinicians (30%
to 50%) reported that the module prompted cancer screening discussions, helped patients get more
involved, improved knowledge, enhanced communication, made clinicians more sensitive to patients’
concerns, and facilitated decisions (Table 3). Although
only 39.0% of clinicians recalled addressing the
patient’s fears/worries, 80.9% of patients said the clinician helped reduce their fears/worries.
Module completion was associated with screening
behavior (Figure 2): completers were more likely to

Characteristics of Decision Module Users
Women were less likely than men to use the module
(Table 2). Within the colorectal cancer screening
cohort, which included both sexes, more men started
the module (P =.03). Similarly, across all phases, men
were more likely than women to share a summary with
their clinician (56.3% vs 37.0%, P <.001). Module use
was lower for patients with no prior screening than
for those previously screened
(P <.001) and for patients who
Table 3. Satisfaction With the Informed Decision-Making Module and
preferred a language other
Reported Impact on Care
than English (P <.001). HisPatient
Clinician
panics tended to be less likely
Agreement, % Agreement, %
than non-Hispanics to start
(n = 277)a
(n = 281)b
Statement or Measure
the module (P =.07). Factors
Doctor believed to have seen response summary
other than socioeconomic status
at time of appointment
also appeared important. Asian
50.0
57.8
Yes
patients, a demographic with
50.0
21.1
No
often high socioeconomic sta0
21.1
Cannot remember
Doctor discussed screening test at visit
tus,45 were least likely to start the
65.5
70.7
Yes
module (P <.001), and African
24.6
20.7
No
American patients were most
9.9
8.6
Cannot remember
likely to complete it (P <.001).
How use of module changed the conversation
Start and completion rates were
41.3
39.0
Motivated patient to talk with doctor
higher for Medicare beneficiaries
39.7
28.1
Prompted doctor to talk with patient
than for commercially insured
33.3
47.3
Did not change anything
patients (P <.001).
9.5
2.1
Other
Impact on Care
The next office visit occurred,
on average, 50 days (range, 0-312
days) after the decision module
session. The average differed by
phase (phase 1 = 160 days, phase
2 = 7 days, and phase 3 = 14 days;
P <.001), although some patients
in each phase did not have a visit
after module use. About 50% to
60% of patients and clinicians
reported the clinician reviewed
the forwarded summary before the
visit. Patients reported that screening was discussed more often
during wellness visits than during
chronic or acute care visits (82.5%,
63.9%, 60.0%, respectively, P
=.03) (Table 3). Patients who forwarded a summary were slightly
more likely to report discussion of
screening than those who did not
(72.9% vs 67.7%, P =.04).

How conversation helped patient with fears or
worries ranked as most important on module
Reduced fears or worries
Did not help with fears or worries
Doctor recalled addressing patients’ fears or worries
about cancer screening
Yes

80.9

NA

19.1

NA

NA

39.0

NA

29.3

NA

31.7

Look and layout were easy to understand

56.0 vs 9.7

NA

Took too long to complete

34.3 vs 29.2

NA

Was easy to complete

72.2 vs 11.1

NA

Helped patient with cancer screening decision

42.6 vs 20.4

44.9 vs 8.2

Made visit more productive

40.7 vs 17.6

38.1 vs 16.3

Got patient more involved with the decision

47.7 vs 17.6

51.7 vs 6.1

Helped to change patient’s screening plans

22.7 vs 30.1

13.6 vs 17.0

Improved patient-doctor communication

37.5 vs 16.7

42.2 vs 12.2

Improved patient’s knowledge before visit

48.1 vs 15.7

45.6 vs 6.1

Made the doctor more sensitive to patient’s needs

27.3 vs 11.6

48.3 vs 10.2

No
Cannot remember
Strongly/somewhat agree vs strongly/somewhat
disagree regarding completion of module and
forwarding of summaryc

NA = not applicable.
Response rate = 44.7%.
Response rate = 45.3%.
c
Response options were strongly agree, somewhat agree, neither agree nor disagree, somewhat disagree, and
strongly disagree. Values for neither agree nor disagree are not reported in table.
a

b
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get screened within 3 months than nonstarters and
noncompleters (P <.001), a pattern suggesting that
they had already made a screening choice—mostly to
get screened. Among patients eligible for colon cancer
screening, completers were more likely than nonstarters to get a colonoscopy (P <.001) or a stool test
(P <.001). Comparing nonstarters with completers,
there was a greater increase in colonoscopies than
stool tests for the latter (P <.001).

DISCUSSION
This pragmatic observational cohort study harnessed
EHR data and patient portal capabilities to create
an automated decision module that could identify
patients likely to be facing common cancer screening decisions, engage and inform patients, clarify
questions and fears, identify next decision steps, and
improve the decision-making process. We found that

practices had large decision burdens—with 1 in 5
patients facing a decision—yet only 20.6% of patients
facing a decision started and 7.9% completed our
decision module. Users reviewed a range of topics,
and one-half of patients forwarded their priorities and
concerns to clinicians. Both patients and clinicians
reported that module completion helped with decisions: one-third to one-half reported it made appointments more productive, got patients more involved
in decisions, broadened knowledge, and improved
communication.
Our proposed decision module is appealing, yet a
clear challenge is getting patients to use such a system.
Decision support use is high in the context of clinical
trials.23,25 Routine use of decision support in clinical
practice, which we tried to automate in this study, is
low (9% to 10% of encounters in implementation trials), however.26 Furthermore, pragmatic trials looking
at patient portal use frequently demonstrate low initial

Figure 2. Relationship of the informed decision-making module with follow-up visits and with breast,
colorectal, and prostate cancer screening.
11,458 Patients with potential
screening decision

79.4% Module nonstarters

20.6% Module starters

38.3% Module completers

61.7% Module noncompleters

51.7% Didn’t share summary
with clinician

91.6% Didn’t share summary
with clinician

48.3% Shared summary
with clinician

3.9% Shared summary
with clinician

19.8% Wellness visit

45.7% No
follow-up visit

24.6% Chronic care
visit

14.1% Wellness visit

21.5% Wellness visit
24.6% Chronic care
visit
22.5% Acute care visit

0.6% Mammogram

54.6% No
follow-up visit

18.1% Chronic care
visit

31.3% No
follow-up visit

12.8% Mammogram

0.0% PSA test

14.3% PSA test

0.7% Colonoscopy

7.9% Colonoscopy

0.0% Stool test

4.6% Stool test

13.2% Acute care
visit

9.9% Acute care
visit

30.7% Mammogram

15.7% Mammogram

22.0% Mammogram

17.2% Mammogram

35.5% PSA test

8.7% PSA test

18.8% PSA test

6.3% PSA test

17.1% Colonoscopy

15.9% Colonoscopy

16.9% Colonoscopy

11.1% Colonoscopy

6.8% Stool test

5.3% Stool test

5.9% Stool test

3.2% Stool test

PSA = prostate-specific antigen.
Note: Percentages of patients who received screening tests were derived from electronic health record data for a period of 3 months after completion of the decision
module. Although the colorectal cancer screening rate appears low, this study included only the subset of practice patients overdue for that screening. On the basis of
prior studies and practice quality program participation, about 70% of patients in the study practices have been screened for colorectal cancer.46
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uptake with increasing use over time as the portal
becomes part of new standard workflows.47,48
Our findings regarding patient use by phase provide
some insight into how such systems could be integrated
into workflow. Linking invitations to visits (phase 2)
resulted in greater response rates and less time between
portal use and visits; inviting anyone with a need (phase
3) resulted in a greater absolute number of users and
may have prompted needed visits. Findings further
suggest some groups of patients (possibly men more
than women and African Americans more than Asians)
and types of decisions (prostate cancer screening more
than breast cancer screening) may derive greater benefit from a decision module, but comparison trials are
needed to fully understand these observations.
Most trials of traditional decision aids demonstrate
reduced use of services with marginal benefit and
increased use of beneficial services.23,49-52 Although
Figure 2 shows decision module users had higher rates
of breast and prostate cancer screening, which may
not be good for screening services with small or zero
net benefit, users self-selected, and module responses
indicated a substantial proportion were already
inclined to be screened. Randomized controlled trials
of similar systems and trials that assess whether decisions better align with values are needed. Additionally,
longer observational periods are required to see the
full increase on desired colorectal cancer screening.
This feasibility study had limitations. It involved a
large population but lacked controls. It relied on surveys
to gauge associations. Completers were more likely to
be screened, but this self-selected sample may have been
more motivated than other patients. We conducted
paired postencounter surveys to elicit feedback from
patients and clinicians after visits; overall response rates
were 45%, and the rate of paired responses was lower.
Confirming this study’s findings in controlled trials will be important and has implications well beyond
cancer screening. Health systems and payers could
expand the role of portals to help patients prepare for
other complex decisions. Implementing this model
of using technology for decision making is likely to
encounter technologic challenges,53-56 and engaging patients online and integrating the process with
practice workflow may not be easy. If, however, future
research confirms the benefits of this approach—more
informed patients, better decisions, and wiser use of
encounter time—the return on investment could offset
the implementation costs and improve care.
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